Cerecor raises $26M in a downsized IPO to fund its depression pipeline

Baltimore biotech Cerecor ($CERCU) raised $26 million in an IPO to bankroll its work on treatments for depression, issuing warrants to bring in the cash it needs. Cerecor priced 4 million units at $6.50 apiece, with each unit including one share of common stock, one warrant to purchase another share and a second warrant redeemable for a half share. With the proceeds, Cerecor is advancing three therapies for major depressive disorder, with two in Phase II and another in preclinical development. Release

Suggested Articles

No biohazardous substances were in the room where the explosion happened, according to the Russian virology center.

Merck has a shot at becoming the first company to receive clearance to sell a vaccine against the virus in the U.S.

Acceleron has chalked up another phase 2 flop as its pipeline thins a little more.